Using time-dependent covariate analysis to elucidate the relation of smoking history to warthin's tumor risk

American Journal of Epidemiology

Volumn 170, Issue 9, 2009, Pages 1178-1185

  Freedman, Laurence S ^a   Oberman, Bernice ^b   Sadetzki, Siegal ^b  

^a Chaim Sheba Medical Center   (Ireland)

^b NONE

Author keywords

Cox regression; Parotid neoplasms; Reaction time; Smoking; Smoking cessation; Time dependent covariate

Indexed keywords

COVARIANCE ANALYSIS; DISEASE PREVALENCE; HEALTH RISK; NONLINEARITY; REACTION RATE; SALIVA; SMOKING; TIME DEPENDENT BEHAVIOR; TUMOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; ISRAEL; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONSET AGE; PAROTID GLAND TUMOR; RISK FACTOR; SALIVARY GLAND; SMOKING; SMOKING CESSATION; SMOKING HABIT; TIME; TUMOR GROWTH; TUMOR LOCALIZATION; WARTHIN TUMOR;

ADENOLYMPHOMA; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SALIVARY GLAND NEOPLASMS; SMOKING; SMOKING CESSATION; TIME FACTORS;

EID: 72049131296     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwp244     Document Type: Article

References (25)

1. Pinkston JA, Cole P. Cigarette smoking and Warthin's tumor. Am J Epidemiol. 1996;144(2):183-187.
2. Poulsen P, Jørgensen K, Grøntved A. Benign and malignant neoplasms of the parotid gland: incidence and histology in the Danish county of Funen. Laryngoscope. 1987;97(1): 102-104.
3. Mortensen KS, Hjortlund J, Bjørndal K, et al. Salivary gland tumors in the county of Funen, 1984-2003. Ugeskr Laeger. 2008;170(7):545-548.
4. Yach D. Tobacco: science, policy and public health. Tobacco smoke and involuntary smoking. Geneva, Switzerland: World Health Organization; 2005. (http://www.scielosp.org/scielo.php?script=sci-arttext&pid= S0042-96862005000500021&lng=en&nrm=iso). (Accessed December 21, 2008).
5. Kotwall CA. Smoking as an etiologic factor in the development of Warthin's tumor of the parotid gland. Am J Surg. 1992;164(6):646-647.
6. Chung YF, Khoo ML, Heng MK, et al. Epidemiology of Warthin's tumour of the parotid gland in an Asian population. Br J Surg. 1999;86(5):661-664.
7. Gallo O, Bocciolini C. Warthin's tumor associated with autoimmune diseases and tobacco use. Acta Otolaryngol. 1997;117(4):623-627.
8. Vories AA, Ramirez SG. Warthin's tumor and cigarette smoking. South Med J. 1997;90(4):416-418.
9. Yoo GH, Eisele DW, Askin FB, et al. Warthin's tumor: a 40-year experience at The Johns Hopkins Hospital. Laryngoscope. 1994;104(7):799-803.
10. Sadetzki S, Oberman B, Mandelzweig L, et al. Smoking and risk of parotid gland tumors: a nationwide case-control study. Cancer. 2008;112(9):1974-1982.
11. Cox DR. Regression models with life tables (with discussion). J Roy Stat Soc (B). 1972;34(2):187-220.
12. Prentice RL, Breslow NE. Retrospective studies and failure time models. Biometrika. 1978;65(1):153-158.
13. Chen K, Lo SH. Case-cohort and case-control analysis with Cox's model. Biometrika. 1999;86(4):755-764.
14. Leffondré K, Abrahamowicz M, Siemiatycki J, et al. Modeling smoking history: a comparison of different approaches. Am J Epidemiol. 2002;156(9):813-823.
15. Harrell FE, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988;80(15):1198-1202.
16. Barlow WE, Ichikawa L, Rosner D, et al. Analysis of case-cohort designs. J Clin Epidemiol. 1999;52(12):1165-1172.
17. Vineis P, Alavanja M, Garte S. Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int J Cancer. 2004;108(1):2-7.
18. Vineis P, Kogevinas M, Simonato L, et al. Levelling-off of the risk of lung and bladder cancer in heavy smokers: an analysis based on multicentric case-control studies and a metabolic interpretation. Mutat Res. 2000;463(1):103-110.
19. Lubin JH, Caporaso NE. Cigarette smoking and lung cancer: modeling total exposure and intensity. Cancer Epidemiol Biomarkers Prev. 2006;15(3):517-523.
20. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health. 1978; 32(4):303-313.
21. Doll R, Hill AB. Mortality in relation to smoking: ten years observations of British doctors. Br Med J. 1964;1(5395):1399-1410.
22. Flanders WD, Lally CA, Zhu BP, et al. Lung cancer mortality in relation to age, duration of smoking and daily cigarette consumption: results from Cancer Prevention Study II. Cancer Res. 2003;63(19):6556-6562.
23. Knoke JD, Shanks TG, Vaughn JW, et al. Lung cancer mortality is related to age in addition to duration and intensity of cigarette smoking: an analysis of CPS-I data. Cancer Epidemiol Biomarkers Prev. 2004;13(6):949-957.
24. Meza R, Hazelton WD, Colditz GA, et al. Analysis of lung cancer incidence in the Nurses' Health and the Health Professionals follow-up studies using a multistage carcino-genesis model. Cancer Causes Control. 2008;19(3):317-328.
25. Bach PB, Kattan MW, Thornquist MD, et al. Variations in lung cancer risk among smokers. J Nat Cancer Inst. 2003;95(6): 470-478.